-

Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 1:30 p.m. Pacific Time.

The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Hologic, Inc.

NASDAQ:HOLX

Release Summary
Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference
Release Versions
$Cashtags

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Social Media Profiles
More News From Hologic, Inc.

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

MARLBOROUGH, Mass.--(BUSINESS WIRE)--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test...

New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA

MARLBOROUGH, Mass.--(BUSINESS WIRE)--New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA...

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking...
Back to Newsroom